ISSN: 2218-676X
Journal Home
Journal Guideline
Translational Cancer Research Q3 Unclaimed
Translational Cancer Research is a journal indexed in SJR in Oncology and Cancer Research with an H index of 39. It has an SJR impact factor of 0,422 and it has a best quartile of Q3. It has an SJR impact factor of 0,422.
Type: Journal
Type of Copyright:
Languages:
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,422
SJR Impact factor39
H Index330
Total Docs (Last Year)1735
Total Docs (3 years)11939
Total Refs2477
Total Cites (3 years)1667
Citable Docs (3 years)1.46
Cites/Doc (2 years)36.18
Ref/DocOther journals with similar parameters
Cancer Management and Research Q3
Journal of Breast Cancer Q3
Breast Cancer: Basic and Clinical Research Q3
Oncology Letters Q3
Clinical Medicine Insights: Oncology Q3
Compare this journals
Aims and Scope
Best articles by citations
Metformin up-regulated miR-107 expression and enhanced the inhibitory effect of miR-107 on gastric cancer growth
View moreExploration of the genomic landscape of a long-term surviving stage III colorectal cancer patient identifies recurrent and rare mutations: a case report
View moreMultiple roles of THY1 in gastric cancer based on data mining
View moreIdentification of an individualized autophagy prognostic index in clear cell renal cell carcinoma patients
View moreCerebral metastases of parathyroid carcinoma: a case report and literature review
View moreHistomorphometric comparative analysis between the oral mucosa of fibrous inflammatory hyperplasia and oral leukoplakia
View moreRelationships between expression of glucose transporter protein-1 and hypoxia inducible factor-1a, prognosis and 18F-FDG uptake in laryngeal and hypopharyngeal carcinomas
View moreExploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers
View moreMethylation of PLIN5 is a crucial biomarker and is involved in ovarian cancer development
View morePI3K/AKT/mTOR pathway in tumor progression of oligodendrogliomas
View moreNLRC5, a valuable marker for the diagnosis and prognostic assessment of hepatocellular carcinoma
View moreClinical outcomes of proximal gastrectomy versus total gastrectomy for locally advanced proximal gastric cancer: a propensity score matching analysis
View moreInteraction between linc01615 and miR-491-5p regulates the survival and metastasis of colorectal cancer cells
View moreAssessing the potential association between Epstein-Barr virus and oral squamous cell carcinoma: a systematic review and meta- analysis
View moreSpred-3 mutation and Ras/Raf/MAPK activation confer acquired resistance to EGFR tyrosine kinase inhibitor in an EGFR mutated NSCLC cell line
View moreDynamic monitoring of serum soluble programmed cell death ligand 1 as a response predictor to chemotherapy in metastatic or recurrent gastrointestinal cancer
View moreHAX-1 overexpression in gastric cancer promotes cell proliferation
View moreAnalysis of factors related to N2- or N3-stage breast cancer associated with 1-2 positive sentinel lymph nodes in Chinese patients
View moreCandidate genes for predicting the survival of patients with gastric cancer: a study based on The Cancer Genome Atlas (TCGA) database
View morePostoperative diffused alveolar hemorrhage complicated by pneumonia after lung cancer surgery in a patient with liver cirrhosis: a case report and review of literatures
View moreProstate cancer: unmet clinical needs and RAD9 as a candidate biomarker for patient management
View moreBone metabolism in Chinese patients after laparoscopic Roux-en-Y gastric bypass
View moreHereditary multiple exostoses complicated with lung cancer with cough as the first symptom: a case report
View moreAdditional treatment prolonged survival of pulmonary artery sarcoma after surgical resection
View more
Comments